BVNKF:OTCMKTS
Bavarian Nordic
36,06 USD
0,00%
(0,00) 1 D
8. okt., 15:46:25 GMT-4 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for BVNKF …
Markedsverdi
2,82 mrd.
Snittvolum
14,00
Volum
0,00
52 u høy
37,22 USD
52 u lav
27,69 USD
Beta
1,46
Utestående aksjer
79,26 mill.
Antall ansatte
2k
Markedsverdi
2,82 mrd.
Snittvolum
14,00
Volum
0,00
52 u høy
37,22 USD
52 u lav
27,69 USD
Beta
1,46
Utestående aksjer
79,26 mill.
Antall ansatte
2k
Nyhetssaker
Fra nettkilder og nyhetspartnere
Invezz
·
for 2 døgn siden
Dow stiger 423 poeng etter teknologireprise, telekomaksjer faller på SpaceX
Invezz
·
for 2 timer siden
Topp 3 katalysatorer for S&P 500-indeksen denne uken: obligasjoner, kvartalstall, KPI
Yahoo Finance
·
for 59 minutter siden
A handful of tech stocks are masking an ugly S&P 500 problem
Pulse 2.0
·
for 36 minutter siden
Eaglebrook Launches Crypto Direct Indexing Platform With S&P Cryptocurrency Top 10 Equal Weight Index
Profil
Bavarian Nordic A/S is a Danish biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany, as well as offices in USA, Canada, and France. The company uses viral vectors and virus-like particles in its research and development.
In July 2025, the company agreed to be acquired by private equity firms Permira and Nordic Capital for 19 billion kr. However, in November, the acquisition failed to gain sufficient support from Bavarian Nordic's shareholders, leading to its termination.
In 2026, Bavarian Nordic was ranked second in Time Magazine's World Most Impactful Companies. Wikipedia
Om Bavarian Nordic
Administrerende direktørPaul Chaplin
Ansatte1,91k
Grunnlagt1. juli 1992
Hovedkontor-
Sektor-
Nettstedbavarian-nordic.com